Novel theoretical and experimental insights enhance BNCT treatment planning accuracy in glioblastoma multiforme.
These findings highlight the relevance of subcellular-scale modeling. The proposed Microdosimetric Model, grounded on experimentally derived microdosimetric corrections, provides a robust framework to improve both the accuracy and the personalization of BNCT treatment planning.
No takes yet. Share an insight, caveat, or question.
Marcaccio et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: